Based on alignment gained with FDA under the Regenerative Medicine Advanced Therapy (RMAT) designation, Neurona plans to conduct the Phase 3 ...

Content by RegenND Naturopathic Clinic. From tennis elbow and Achilles tendonitis to osteoarthritis and rotator cuff injuries ...

Some promising studies on reverse ageing suggest we could turn back the clock. Here's what experts want you to know about ...

ADIA Nutrition Inc. (OTC Pink: ADIA), a trailblazer in healthcare and supplementation, proudly announces the launch of Adia ...

Some promising studies on reverse aging suggest we could turn back the clock. Here's what experts want you to know about ...

The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching US$8.85 billion ...

Britecyte’s Adipose Tissue Allograft Earns "Safe to Proceed" Status from FDA; Marks Significant Achievement in Field of ...

The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through innovative gene editing approaches.

The US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to AskBio’s investigational Parkinson’s disease (PD) gene therapy. The FDA grants RMAT ...

Dry Eye Syndrome Treatment Market Advancements in AI Diagnostics, Drug-Device Therapies, and Regenerative Medicine are Fueling Market Expan ...